Please login to the form below

Not currently logged in
Email:
Password:

Access to Medicines Index

This page shows the latest Access to Medicines Index news and features for those working in and with pharma, biotech and healthcare.

GSK tops Access to Medicines Index for fifth time running

GSK tops Access to Medicines Index for fifth time running

GSK tops Access to Medicines Index for fifth time running. Leads J&J and Novartis in 'needs-orientation' while Roche and Astellas lag. ... The Access to Medicines Index 2016. View the Access to Medicines Index 2016.

Latest news

  • GSK unveils access plan for low-income countries GSK unveils access plan for low-income countries

    The company's chief executive Sir Andrew Witty - who will step down next year - announced the measure just ahead of the UN High Level Panel on Access to Medicines yesterday. ... GSK already has a good track record on medicines access, ranking at number

  • Novartis to make 15 drugs available at $1 a month Novartis to make 15 drugs available at $1 a month

    Novartis has launched an access programme aimed at low-and middle-income countries that will make 15 of its medicines for chronic diseases available at a knockdown price. ... Novartis was ranked fourth in the 2014 Access to Medicines Index funded by the

  • GSK tops pharma access to medicines table GSK tops pharma access to medicines table

    The biannual Access To Medicines Index (ATMI) - which is funded by the Bill &Melinda Gates Foundation and the UK and Dutch governments - puts GlaxoSmithKline at the top of its rankings in ... The Access to Medicines Index 2014. "In recent years,

  • Archive listing

    GSK tops Access to Medicines Index for fifth time running. ... Warns of deprioritised status if negotiators fail to secure access to the single market. .

  • EU pharma heading efforts to get drugs to the poor

    efforts to increase the level of access to affordable medicines for the poor. ... The Access to Medicines Index was launched on June 16 and shows that only one US manufacturer, Merck &Co, which came third, has made it into the top seven.

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics